Dave Holt is a Partner at IP law firm, Potter Clarkson. He specialises in non-contentious intellectual property law, with experience in significant contentious patent matters. Dave specialises in the biotechnology, synthetic biology and cancer therapeutics sectors, with a major part of his practice focussing on novel therapeutics.